Literature DB >> 6927280

Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.

J M Swenson, C Thornsberry, V A Silcox.   

Abstract

A total of 18 strains of Mycobacterium fortuitum, 15 strains of M. chelonei, and 31 strains of M. chelonei-like organisms were tested by both broth microdilution and agar dilution to determine their susceptibility to 34 antimicrobial agents. All strains grew well enough in cation-supplemented Mueller-Hinton broth for endpoints to be read after 72 h of incubation. Some strains of M. chelonei did not grow on Mueller-Hinton agar. A few discrepancies were noted between the broth and agar procedures. For M. fortuitum, doxycycline, minocycline, amikacin, sulfamethoxazole, and sulfamethoxazole-trimethoprim were the most active agents. For M. chelonei, amikacin, sisomicin, tobramycin, and erythromycin were the most active agents. The M. chelonei-like organisms were most susceptible to ampicillin, doxycycline, minocycline, amikacin, erythromycin, sulfamethoxazole, and sulfamethoxazole-trimethoprim. Broth microdilution appears to be a reliable method for susceptibility testing of rapidly growing mycobacteria, although clinical studies are needed to determine how well in vitro results correlate with therapeutic in vivo outcome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6927280      PMCID: PMC183707          DOI: 10.1128/AAC.22.2.186

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

2.  In vitro susceptibility of mycobacteria to rifampin.

Authors:  J K McClatchy; R F Waggoner; W Lester
Journal:  Am Rev Respir Dis       Date:  1969-08

3.  Mycobacterium fortuitum--a human pathogen.

Authors:  W L Hand; J P Sanford
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

4.  Problems in diagnosis and therapy of Mycobacterium fortuitum infections.

Authors:  J R Dalovisio; G A Pankey
Journal:  Am Rev Respir Dis       Date:  1978-04

5.  Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice.

Authors:  W E Sanders; R Cacciatore; H Valdez; I Pejovic; F P Dunbar
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

7.  Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Authors:  R J Wallace; J R Dalovisio; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

8.  Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.

Authors:  D F Welch; M T Kelly
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

9.  Disseminated Mycobacterium chelonei infection: response to sulfonamides.

Authors:  A D Tice; R J Solomon
Journal:  Am Rev Respir Dis       Date:  1979-07

10.  In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.

Authors:  J R Dalovisio; G A Pankey
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

View more
  49 in total

1.  Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.

Authors:  G L Woods; J S Bergmann; F G Witebsky; G A Fahle; B Boulet; M Plaunt; B A Brown; R J Wallace; A Wanger
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Sequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA bacterial identification system.

Authors:  J B Patel; D G Leonard; X Pan; J M Musser; R E Berman; I Nachamkin
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.

Authors:  A M Nilius; M H Bui; L Almer; D Hensey-Rudloff; J Beyer; Z Ma; Y S Or; R K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Large-scale outbreak of infection with Mycobacterium chelonae subsp. abscessus after penicillin injection.

Authors:  Yang Zhibang; Zhang BiXia; Lu Qishan; Chen Lihao; Liu Xiangquan; Li Huaping
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

5.  Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.

Authors:  R J Wallace; D R Nash; L C Steele; V Steingrube
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

6.  In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.

Authors:  Barbara A Brown-Elliott; Jessica Killingley; Sruthi Vasireddy; Linda Bridge; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

Review 7.  Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.

Authors:  R J Wallace
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 8.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  P Hohl; M Salfinger; F M Kafader
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

10.  Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism.

Authors:  R J Wallace; V A Silcox; M Tsukamura; B A Brown; J O Kilburn; W R Butler; G Onyi
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.